Christopher Matthew Galeta - 28 Sep 2026 Form 4 Insider Report for Caring Brands, Inc. (CABR)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
30 Sep 2026, 06:14:48 UTC
Prior SEC filing
15 Dec 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Christopher Matthew Galeta

Key filing fact

Christopher Matthew Galeta filed Form 4 for Caring Brands, Inc. (CABR) on 30 Sep 2026.

Key facts

  • This page summarizes Christopher Matthew Galeta's Form 4 filing for Caring Brands, Inc. (CABR).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 30 Sep 2026, 06:14.

Change

  • Previous filing in this sequence was filed on 15 Dec 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002089464 Primary reporting owner

Galeta Christopher Matthew

Relationship
Director
Address
C/O CARING BRANDS, INC. 130 S INDIAN, RIVER DRIVE, SUITE 202 PBM# 1232, FORT PIERCE
Signature
/s/ Christopher Matthew Galeta
Signature date
29 Sep 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CABR transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value
Shares
+25,000
Change %
+100%
Price
$0.000000*
Shares after
50,000
Date
28 Sep 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
25,000
Exercise price
$1.24
Footnotes
F1, F2, F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

On September 28, 2026, at the recommendation of the Issuer's Compensation Committee, the Issuer's Board of Directors approved this option grant under the Company's equity incentive plan.

Footnote F2

The options vested immediately on September 28, 2026.

Footnote F3

Includes the options previously issued to the Reporting Person.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .